Acknowledgement
This research was supported by the Basic Research Program through the National Research Foundation of Korea (NRF) funded by MSIT (RS-2023-00208173, RS-2023-00207868).
References
- Thrift AP and Nguyen TH (2021) Gastric cancer epidemiology. Gastrointest Endosc Clin N Am 31, 425-439 https://doi.org/10.1016/j.giec.2021.03.001
- Alsina M, Arrazubi V, Diez M and Tabernero J (2023) Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol 20, 155-170 https://doi.org/10.1038/s41575-022-00703-w
- Al-Batran SE, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393, 1948-1957 https://doi.org/10.1016/S0140-6736(18)32557-1
- Di Martino M, Primavesi F, Syn N et al (2021) Perioperative chemotherapy versus surgery alone for resectable colorectal liver metastases: an international multicentre propensity score matched analysis on long-term outcomes according to established prognostic risk scores. HPB (Oxford) 23, 1873-1885 https://doi.org/10.1016/j.hpb.2021.04.026
- Smyth EC, Verheij M, Allum W et al (2016) Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 27, v38-v49 https://doi.org/10.1093/annonc/mdw350
- Viale PH (2020) The American cancer society's facts & figures: 2020 edition. J Adv Pract Oncol 11, 135-136
- Harrigan JA, Jacq X, Martin NM and Jackson SP (2018) Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov 17, 57-78 https://doi.org/10.1038/nrd.2017.152
- Peth A, Besche HC and Goldberg AL (2009) Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. Mol Cell 36, 794-804 https://doi.org/10.1016/j.molcel.2009.11.015
- Komander D, Clague MJ and Urbe S (2009) Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10, 550-563 https://doi.org/10.1038/nrm2731
- Kwon YT and Ciechanover A (2017) The ubiquitin code in the ubiquitin-proteasome system and autophagy. Trends Biochem Sci 42, 873-886 https://doi.org/10.1016/j.tibs.2017.09.002
- Sun T, Liu Z and Yang Q (2020) The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer 19, 146
- Han S, Wang R, Zhang Y et al (2022) The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci 18, 2292-2303 https://doi.org/10.7150/ijbs.69411
- Lee CS, Kim S, Hwang G and Song J (2021) Deubiquitinases: modulators of different types of regulated cell death. Int J Mol Sci 22, 4352
- Jolly LA, Kumar R, Penzes P, Piper M and Gecz J (2022) The DUB club: deubiquitinating enzymes and neurodevelopmental disorders. Biol Psychiatry 92, 614-625 https://doi.org/10.1016/j.biopsych.2022.03.022
- Liu Y, Xu J, Wang Y et al (2022) USP14 regulates cell cycle progression through deubiquitinating CDK1 in breast cancer. Acta Biochim Biophys Sin (Shanghai) 54, 1610-1618 https://doi.org/10.3724/abbs.2022160
- Schwertman P, Bekker-Jensen S and Mailand N (2016) Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers. Nat Rev Mol Cell Biol 17, 379-394 https://doi.org/10.1038/nrm.2016.58
- An T, Lu Y, Gong Z et al (2022) Research progress for targeting deubiquitinases in gastric cancers. Cancers (Basel) 14, 5831
- Zhu Y, Zhang C, Gu C, Li Q and Wu N (2016) Function of deubiquitinating enzyme USP14 as oncogene in different types of cancer. Cell Physiol Biochem 38, 993-1002 https://doi.org/10.1159/000443051
- Han KH, Kwak M, Lee TH et al (2019) USP14 inhibition regulates tumorigenesis by inducing autophagy in lung cancer in vitro. Int J Mol Sci 20, 5300
- Yang JS, Yoon N, Kong M, Jung BH, Lee H and Park J (2021) USP14 regulates cancer cell growth in a fatty acid synthase-independent manner. Int J Mol Sci 22, 13437
- Fu Y, Ma G, Liu G et al (2018) USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer. Cancer Med 7, 5577-5588 https://doi.org/10.1002/cam4.1770
- Chen XY, Liang R, Yi YC et al (2021) The m(6)A reader YTHDF1 facilitates the tumorigenesis and metastasis of gastric cancer via USP14 translation in an m(6)A-dependent manner. Front Cell Dev Biol 9, 647702
- Petryszyn P, Chapelle N and Matysiak-Budnik T (2020) Gastric cancer: where are we heading? Dig Dis 38, 280-285 https://doi.org/10.1159/000506509
- Pasechnikov V, Chukov S, Fedorov E, Kikuste I and Leja M (2014) Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol 20, 13842-13862 https://doi.org/10.3748/wjg.v20.i38.13842
- Song Z, Wu Y, Yang J, Yang D and Fang X (2017) Progress in the treatment of advanced gastric cancer. Tumour Biol 39, 1010428317714626
- Chen VC, Huang JY, Tzang BS, Hsu TC and McIntyre RS (2022) Synergistic effects of the combinational use of escitalopram oxalate and 5-fluorouracil on the inhibition of gastric cancer SNU-1 cells. Int J Mol Sci 23, 16179
- Liu B, Chen J and Zhang S (2019) Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: therapeutic implication. Life Sci 239, 116875
- He F, Chen Y, He D and He S (2023) USP14-mediated deubiquitination of SIRT1 in macrophage promotes fatty acid oxidation amplification and M2 phenotype polarization. Biochem Biophys Res Commun 646, 19-29 https://doi.org/10.1016/j.bbrc.2022.12.076
- Zhu L, Yang S, He S et al (2016) Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis. J Mol Histol 47, 69-80 https://doi.org/10.1007/s10735-015-9650-3
- Zhu Y, Zhang Y, Sui Z, Zhang Y, Liu M and Tang H (2017) USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells. Oncotarget 8, 48725-48736 https://doi.org/10.18632/oncotarget.10706
- Kim DS, Min K and Lee SK (2020) Cell cycle dysregulation is associated with 5-fluorouracil resistance in gastric cancer cells. Anticancer Res 40, 3247-3254 https://doi.org/10.21873/anticanres.14306
- Kang BW, Kim JG, Kwon OK, Chung HY and Yu W (2014) Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan. World J Gastroenterol 20, 5396-5402 https://doi.org/10.3748/wjg.v20.i18.5396
- Longley DB, Harkin DP and Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3, 330-338
- Azwar S, Seow HF, Abdullah M, Faisal Jabar M and Mohtarrudin N (2021) Recent updates on mechanisms of resistance to 5-fluorouracil and reversal strategies in colon cancer treatment. Biology (Basel) 10, 854